Press Releases
4 hours ago
Top Nutritional Supplement Manufacturer Sets New Standards for Quality and Innovation
Neutral
EIN Presswire
Feb. 4, 2026
Health & Wellness Industry in 2026: Key Trends and Transformations
Indeterminate
GlobeNewswire, Inc.
Feb. 3, 2026
Heart health research from MVP
Gov't Institution
U.S. Department of Veterans Affairs
Owner: American Government
Feb. 4, 2026
Prime Minister Golob: Resilience means having access to food, health care, and adequate infrastructure
Gov't Institution
Government of Slovenia
Owner: Slovenian Government
17 hours ago
Best Supplements Founder Felix Hesse Tackles Industry Transparency After Overcoming Debilitating Health Crisis
Indeterminate
GlobeNewswire, Inc.
Feb. 4, 2026
Natural Health Trends Reports Fourth Quarter and Full Year 2025 Financial Results
Indeterminate
GlobeNewswire, Inc.
Feb. 4, 2026
Proscia Named Global 2026 Best in KLAS for Digital Pathology in Europe
Indeterminate
GlobeNewswire, Inc.
Feb. 4, 2026
Tilray’s CC Pharma Recognized as a TOP 100 Innovator in Germany
Indeterminate
GlobeNewswire, Inc.
Feb. 4, 2026
Top 10 Medical Device Companies Driving Innovation in Global Healthcare, 2026
Neutral
EIN Presswire
2 hours ago
Riddle Acquires Convert: Contentbird Convert Becomes Convert by Riddle
Neutral
EIN Presswire
Feb. 3, 2026
AI-Enabled Wound Analysis Market to Triple by 2033 as Healthcare AI Accelerates - SRI
Neutral
EIN Presswire
Feb. 3, 2026
The 10 Best European Countries to Retire Abroad - VALMERAND 2026 Study
Neutral
EIN Presswire
Feb. 3, 2026
Femasys Expands European Commercial Footprint with Swiss Partner for FemBloc, FemaSeed, and Portfolio Products
Indeterminate
GlobeNewswire, Inc.
Feb. 3, 2026
Rêve Med Spa Introduces the Matrix® Skin Renewal Platform: A Revolutionary Approach to Skin Health
Neutral
EIN Presswire
Feb. 2, 2026
Spain Rebukes Israel's Move to Ban Doctors Without Borders in Gaza
Indeterminate
MENAFN
Owner: Sawsan Dababneh & Ramzi AbdelJaber
Feb. 2, 2026
Nutritive Sweetener Market Size to Exceed USD 37.97 Billion by 2035 | Towards FnB
Indeterminate
GlobeNewswire, Inc.
2 hours ago
Alvotech Announces Positive Top-Line Results from Pivotal Pharmacokinetic Study for Proposed Biosimilar to Entyvio®
Indeterminate
GlobeNewswire, Inc.